Cagrilintide

Cagrilintide is a synthetic peptide analog designed to act as a dual amylin and calcitonin receptor agonist. It modulates neuroendocrine pathways involved in appetite regulation and energy homeostasis through receptor-mediated signaling. This compound has been evaluated in peer-reviewed literature for its potential role in influencing metabolic processes. Amylin Receptor AgonismCagrilintide exhibits agonist activity at amylin receptors, which are associated with supporting satiety signaling pathways. Calcitonin Receptor EngagementCagrilintide engages calcitonin receptors, contributing to modulation of gastrointestinal motility and gastric emptying rates. Central Food Intake RegulationCagrilintide has been studied for its role in regulating food intake behavior via central nervous system pathways. Energy Expenditure EffectsCagrilintide demonstrates effects on energy expenditure mechanisms in preclinical models. Glucose Metabolism InfluenceCagrilintide has been evaluated for its influence on glucose metabolism parameters in animal studies. This product is intended for use by licensed healthcare providers in clinical settings. It is not intended for consumer sale. Buyer/doctor has determined and documented that the use of this product is appropriate for the patient based on the assessment of the patient's needs. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For professional use only.